{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T05:59:22Z","timestamp":1787032762660,"version":"build-2736575974"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,4,26]]},"DOI":"10.7759\/cureus.38136","type":"journal-article","created":{"date-parts":[[2023,4,26]],"date-time":"2023-04-26T05:45:16Z","timestamp":1682487916000},"source":"Crossref","is-referenced-by-count":19,"title":["Gonadotropin-Releasing Hormone (GnRH)\/GnRH Receptors and Their Role in the Treatment of Endometriosis"],"prefix":"10.7759","author":[{"given":"Christina","family":"Resta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athanasios","family":"Moustogiannis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eirini","family":"Chatzinikita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitris","family":"Malligiannis Ntalianis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos","family":"Malligiannis Ntalianis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasios","family":"Philippou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Koutsilieris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaos","family":"Vlahos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajog.2018.12.039","article-title":"Clinical diagnosis of endometriosis: a call to action","volume":"220","author":"Agarwal SK","year":"2019","unstructured":"Agarwal SK, Chapron C, Giudice LC, et al.. Clinical diagnosis of endometriosis: a call to action. Am J Obstet Gynecol. 2019, 220:354.e1-354.e12. 10.1016\/j.ajog.2018.12.039","journal-title":"Am J Obstet Gynecol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)30187-3","article-title":"Trends in premature mortality in the USA by sex, race, and ethnicity from 1999 to 2014: an analysis of death certificate data","volume":"389","author":"Shiels MS","year":"2017","unstructured":"Shiels MS, Chernyavskiy P, Anderson WF, et al.. Trends in premature mortality in the USA by sex, race, and ethnicity from 1999 to 2014: an analysis of death certificate data. Lancet. 2017, 389:1043-54. 10.1016\/S0140-6736(17)30187-3","journal-title":"Lancet"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.g1752","article-title":"Endometriosis","volume":"348","author":"Hickey M","year":"2014","unstructured":"Hickey M, Ballard K, Farquhar C. Endometriosis. BMJ. 2014, 348:g1752. 10.1136\/bmj.g1752","journal-title":"BMJ"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1089\/jwh.2016.6003","article-title":"Factors associated with time to endometriosis diagnosis in the United States","volume":"26","author":"Soliman AM","year":"2017","unstructured":"Soliman AM, Fuldeore M, Snabes MC. Factors associated with time to endometriosis diagnosis in the United States. J Womens Health (Larchmt). 2017, 26:788-97. 10.1089\/jwh.2016.6003","journal-title":"J Womens Health (Larchmt)"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1093\/humrep\/det457","article-title":"ESHRE guideline: management of women with endometriosis","volume":"29","author":"Dunselman GA","year":"2014","unstructured":"Dunselman GA, Vermeulen N, Becker C, et al.. ESHRE guideline: management of women with endometriosis. Hum Reprod. 2014, 29:400-12. 10.1093\/humrep\/det457","journal-title":"Hum Reprod"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1097\/AOG.0b013e3181e8b073","article-title":"Practice bulletin no. 114: management of endometriosis","volume":"116","year":"2010","unstructured":"Practice bulletin no. 114. management of endometriosis. Obstet Gynecol. 2010, 116:223-36. 10.1097\/AOG.0b013e3181e8b073","journal-title":"Obstet Gynecol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1097\/GRF.0000000000000292","article-title":"Medical management of endometriosis","volume":"60","author":"Rafique S","year":"2017","unstructured":"Rafique S, Decherney AH. Medical management of endometriosis. Clin Obstet Gynecol. 2017, 60:485-96. 10.1097\/GRF.0000000000000292","journal-title":"Clin Obstet Gynecol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.bpobgyn.2020.05.004","article-title":"Progesterone and abnormal uterine bleeding\/menstrual disorders","volume":"69","author":"Jewson M","year":"2020","unstructured":"Jewson M, Purohit P, Lumsden MA. Progesterone and abnormal uterine bleeding\/menstrual disorders. Best Pract Res Clin Obstet Gynaecol. 2020, 69:62-73. 10.1016\/j.bpobgyn.2020.05.004","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2013.07.008","article-title":"Continuous versus cyclic use of oral contraceptives after surgery for symptomatic endometriosis: a prospective cohort study","volume":"100","author":"Vlahos N","year":"2013","unstructured":"Vlahos N, Vlachos A, Triantafyllidou O, Vitoratos N, Creatsas G. Continuous versus cyclic use of oral contraceptives after surgery for symptomatic endometriosis: a prospective cohort study. Fertil Steril. 2013, 100:1337-42. 10.1016\/j.fertnstert.2013.07.008","journal-title":"Fertil Steril"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000346","article-title":"Gonadotrophin-releasing hormone analogues for pain associated with endometriosis","author":"Prentice A","year":"2000","unstructured":"Prentice A, Deary AJ, Goldbeck-Wood S, Farquhar C, Smith SK. Gonadotrophin-releasing hormone analogues for pain associated with endometriosis. Cochrane Database Syst Rev. 2000, CD000346. 10.1002\/14651858.CD000346","journal-title":"Cochrane Database Syst Rev"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.4103\/0974-1208.142476","article-title":"Gonadotropin-releasing hormone analogs: understanding advantages and limitations","volume":"7","author":"Kumar P","year":"2014","unstructured":"Kumar P, Sharma A. Gonadotropin-releasing hormone analogs: understanding advantages and limitations. J Hum Reprod Sci. 2014, 7:170-4. 10.4103\/0974-1208.142476","journal-title":"J Hum Reprod Sci"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1177\/1933719114549848","article-title":"Elagolix, an oral GnRH antagonist, versus subcutaneous depot medroxyprogesterone acetate for the treatment of endometriosis: effects on bone mineral density","volume":"21","author":"Carr B","year":"2014","unstructured":"Carr B, Dmowski WP, O'Brien C, et al.. Elagolix, an oral GnRH antagonist, versus subcutaneous depot medroxyprogesterone acetate for the treatment of endometriosis: effects on bone mineral density. Reprod Sci. 2014, 21:1341-51. 10.1177\/1933719114549848","journal-title":"Reprod Sci"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.5301\/je.5000157","article-title":"Elagolix, an oral GnRH antagonist for endometriosis-associated pain: a randomized controlled study","volume":"5","author":"Carr B","year":"2013","unstructured":"Carr B, Giudice L, Dmowski WP, et al.. Elagolix, an oral GnRH antagonist for endometriosis-associated pain: a randomized controlled study. J Endometr Pelvic Pain Disord. 2013, 5:105-15. 10.5301\/je.5000157","journal-title":"J Endometr Pelvic Pain Disord"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1177\/1933719113497292","article-title":"Elagolix treatment for endometriosis-associated pain: results from a phase 2, randomized, double-blind, placebo-controlled study","volume":"21","author":"Diamond MP","year":"2014","unstructured":"Diamond MP, Carr B, Dmowski WP, et al.. Elagolix treatment for endometriosis-associated pain: results from a phase 2, randomized, double-blind, placebo-controlled study. Reprod Sci. 2014, 21:363-71. 10.1177\/1933719113497292","journal-title":"Reprod Sci"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1016\/0006-291X(71)90491-8","article-title":"Synthesis of the porcine LH- and FSH-releasing hormone by the solid-phase method","volume":"45","author":"Matsuo H","year":"1971","unstructured":"Matsuo H, Arimura A, Nair RM, Schally AV. Synthesis of the porcine LH- and FSH-releasing hormone by the solid-phase method. Biochem Biophys Res Commun. 1971, 45:822-7. 10.1016\/0006-291X(71)90491-8","journal-title":"Biochem Biophys Res Commun"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.69.1.278","article-title":"Primary structure of the ovine hypothalamic luteinizing hormone-releasing factor (LRF) (LH-hypothalamus-LRF-gas chromatography-mass spectrometry-decapeptide-Edman degradation)","volume":"69","author":"Burgus R","year":"1972","unstructured":"Burgus R, Butcher M, Amoss M, et al.. Primary structure of the ovine hypothalamic luteinizing hormone-releasing factor (LRF) (LH-hypothalamus-LRF-gas chromatography-mass spectrometry-decapeptide-Edman degradation). Proc Natl Acad Sci U S A. 1972, 69:278-82. 10.1073\/pnas.69.1.278","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.anireprosci.2005.05.032","article-title":"GnRHs and GnRH receptors","volume":"88","author":"Millar RP","year":"2005","unstructured":"Millar RP. GnRHs and GnRH receptors. Anim Reprod Sci. 2005, 88:5-28. 10.1016\/j.anireprosci.2005.05.032","journal-title":"Anim Reprod Sci"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1016\/s0003-4401(05)80005-1","article-title":"[Recent data on GnRH receptors] (Article in French)","volume":"39","author":"Millar R","year":"2005","unstructured":"Millar R. [Recent data on GnRH receptors] (Article in French). Ann Urol (Paris). 2005, 39:S32-6. 10.1016\/s0003-4401(05)80005-1","journal-title":"Ann Urol (Paris)"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.med.45.1.391","article-title":"Gonadotropin-releasing hormone and its analogs","volume":"45","author":"Conn PM","year":"1994","unstructured":"Conn PM, Crowley WF Jr. Gonadotropin-releasing hormone and its analogs. Annu Rev Med. 1994, 45:391-405. 10.1146\/annurev.med.45.1.391","journal-title":"Annu Rev Med"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.95.1.305","article-title":"Second gene for gonadotropin-releasing hormone in humans","volume":"95","author":"White RB","year":"1998","unstructured":"White RB, Eisen JA, Kasten TL, Fernald RD. Second gene for gonadotropin-releasing hormone in humans. Proc Natl Acad Sci U S A. 1998, 95:305-9. 10.1073\/pnas.95.1.305","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2008-0127","article-title":"Gonadotropin-releasing hormones I and II induce apoptosis in human granulosa cells","volume":"93","author":"Hong IS","year":"2008","unstructured":"Hong IS, Cheung AP, Leung PC. Gonadotropin-releasing hormones I and II induce apoptosis in human granulosa cells. J Clin Endocrinol Metab. 2008, 93:3179-85. 10.1210\/jc.2008-0127","journal-title":"J Clin Endocrinol Metab"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1530\/REP-08-0397","article-title":"GnRH signaling in intrauterine tissues","volume":"137","author":"Wu HM","year":"2009","unstructured":"Wu HM, Wang HS, Huang HY, Soong YK, MacCalman CD, Leung PC. GnRH signaling in intrauterine tissues. Reproduction. 2009, 137:769-77. 10.1530\/REP-08-0397","journal-title":"Reproduction"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2016-3845","article-title":"Dose-dependent suppression of gonadotropins and ovarian hormones by elagolix in healthy premenopausal women","volume":"102","author":"Ng J","year":"2017","unstructured":"Ng J, Chwalisz K, Carter DC, Klein CE. Dose-dependent suppression of gonadotropins and ovarian hormones by elagolix in healthy premenopausal women. J Clin Endocrinol Metab. 2017, 102:1683-91. 10.1210\/jc.2016-3845","journal-title":"J Clin Endocrinol Metab"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1006\/gcen.1994.1134","article-title":"Effects of lamprey gonadotropin-releasing hormone-III on steroidogenesis and spermiation in male sea lampreys","volume":"95","author":"Deragon KL","year":"1994","unstructured":"Deragon KL, Sower SA. Effects of lamprey gonadotropin-releasing hormone-III on steroidogenesis and spermiation in male sea lampreys. Gen Comp Endocrinol. 1994, 95:363-7. 10.1006\/gcen.1994.1134","journal-title":"Gen Comp Endocrinol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1507\/endocrj.k09e-185","article-title":"GnRH pulsatility, the pituitary response and reproductive dysfunction","volume":"56","author":"Tsutsumi R","year":"2009","unstructured":"Tsutsumi R, Webster NJ. GnRH pulsatility, the pituitary response and reproductive dysfunction. Endocr J. 2009, 56:729-37. 10.1507\/endocrj.k09e-185","journal-title":"Endocr J"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/b978-0-12-571143-2.50008-3","article-title":"The mammalian GnRH gene and its pivotal role in reproduction","volume":"43","author":"Seeburg PH","year":"1987","unstructured":"Seeburg PH, Mason AJ, Stewart TA, Nikolics K. The mammalian GnRH gene and its pivotal role in reproduction. Recent Prog Horm Res. 1987, 43:69-98. 10.1016\/b978-0-12-571143-2.50008-3","journal-title":"Recent Prog Horm Res"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/17.15.6403","article-title":"The complete nucleotide sequence of the human gonadotropin-releasing hormone gene","volume":"17","author":"Hayflick JS","year":"1989","unstructured":"Hayflick JS, Adelman JP, Seeburg PH. The complete nucleotide sequence of the human gonadotropin-releasing hormone gene. Nucleic Acids Res. 1989, 17:6403-4. 10.1093\/nar\/17.15.6403","journal-title":"Nucleic Acids Res"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2017.00180","article-title":"Progress and challenges in the search for the mechanisms of pulsatile gonadotropin-releasing hormone secretion","volume":"8","author":"Constantin S","year":"2017","unstructured":"Constantin S. Progress and challenges in the search for the mechanisms of pulsatile gonadotropin-releasing hormone secretion. Front Endocrinol (Lausanne). 2017, 8:180. 10.3389\/fendo.2017.00180","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2019.00329","article-title":"Modulation of gonadotropin-releasing hormone neuron activity and secretion in mice by non-peptide neurotransmitters, gasotransmitters, and gliotransmitters","volume":"10","author":"Spergel DJ","year":"2019","unstructured":"Spergel DJ. Modulation of gonadotropin-releasing hormone neuron activity and secretion in mice by non-peptide neurotransmitters, gasotransmitters, and gliotransmitters. Front Endocrinol (Lausanne). 2019, 10:329. 10.3389\/fendo.2019.00329","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.1016\/j.yfrne.2008.07.001","article-title":"Signaling by G-protein-coupled receptor (GPCR): studies on the GnRH receptor","volume":"30","author":"Naor Z","year":"2009","unstructured":"Naor Z. Signaling by G-protein-coupled receptor (GPCR): studies on the GnRH receptor. Front Neuroendocrinol. 2009, 30:10-29. 10.1016\/j.yfrne.2008.07.001","journal-title":"Front Neuroendocrinol"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.humrep.a136964","article-title":"The value of GnRH analogue therapy in IVF in women with unexplained infertility","volume":"4","author":"Ashkenazi J","year":"1989","unstructured":"Ashkenazi J, Dicker D, Feldberg D, Goldman GA, Yeshaya A, Goldman JA. The value of GnRH analogue therapy in IVF in women with unexplained infertility. Hum Reprod. 1989, 4:667-9. 10.1093\/oxfordjournals.humrep.a136964","journal-title":"Hum Reprod"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1002\/stem.2222","article-title":"Loss of endometrial plasticity in recurrent pregnancy loss","volume":"34","author":"Lucas ES","year":"2016","unstructured":"Lucas ES, Dyer NP, Murakami K, et al.. Loss of endometrial plasticity in recurrent pregnancy loss. Stem Cells. 2016, 34:346-56. 10.1002\/stem.2222","journal-title":"Stem Cells"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1016\/j.ygyno.2014.05.018","article-title":"Endometrial cancer: a review and current management strategies: part I","volume":"134","author":"Burke WM","year":"2014","unstructured":"Burke WM, Orr J, Leitao M, et al.. Endometrial cancer: a review and current management strategies: part I. Gynecol Oncol. 2014, 134:385-92. 10.1016\/j.ygyno.2014.05.018","journal-title":"Gynecol Oncol"},{"key":"ref34","article-title":"Comparison of LHRH agonists and antagonists antifertility and therapeutic developments","author":"Corbin A","year":"1984","unstructured":"Corbin A, Frederick J, Jones B, et al.. Comparison of LHRH agonists and antagonists antifertility and therapeutic developments. LHRH and its analogs. Labrie F, Belanger A, Dupont A (ed): Elsevier Science Publishers, New York, NY; 1984. 95."},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2016.10.022","article-title":"Estrogen-progestins and progestins for the management of endometriosis","volume":"106","author":"Vercellini P","year":"2016","unstructured":"Vercellini P, Buggio L, Berlanda N, Barbara G, Somigliana E, Bosari S. Estrogen-progestins and progestins for the management of endometriosis. Fertil Steril. 2016, 106:1552-1571.e2. 10.1016\/j.fertnstert.2016.10.022","journal-title":"Fertil Steril"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1210\/edrv-7-1-44","article-title":"Gonadotropin-releasing hormone analog design. Structure-function studies toward the development of agonists and antagonists: rationale and perspective","volume":"7","author":"Karten MJ","year":"1986","unstructured":"Karten MJ, Rivier JE. Gonadotropin-releasing hormone analog design. Structure-function studies toward the development of agonists and antagonists: rationale and perspective. Endocr Rev. 1986, 7:44-66. 10.1210\/edrv-7-1-44","journal-title":"Endocr Rev"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.1021\/mp0700514","article-title":"Targeted therapy of breast and gynecological cancers with cytotoxic analogues of peptide hormones","volume":"4","author":"Engel JB","year":"2007","unstructured":"Engel JB, Schally AV, Dietl J, Rieger L, H\u00f6nig A. Targeted therapy of breast and gynecological cancers with cytotoxic analogues of peptide hormones. Mol Pharm. 2007, 4:652-8. 10.1021\/mp0700514","journal-title":"Mol Pharm"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1210\/jcem-66-2-327","article-title":"Gonadotropin-releasing hormone (GnRH) analog suppression renders polycystic ovarian disease patients more susceptible to ovulation induction with pulsatile GnRH","volume":"66","author":"Filicori M","year":"1988","unstructured":"Filicori M, Campaniello E, Michelacci L, Pareschi A, Ferrari P, Bolelli G, Flamigni C. Gonadotropin-releasing hormone (GnRH) analog suppression renders polycystic ovarian disease patients more susceptible to ovulation induction with pulsatile GnRH. J Clin Endocrinol Metab. 1988, 66:327-33. 10.1210\/jcem-66-2-327","journal-title":"J Clin Endocrinol Metab"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1993.tb43872.x","article-title":"Therapeutic use of gonadotropin-releasing hormone agonists in polycystic ovarian syndrome","volume":"687","author":"Markussis V","year":"1993","unstructured":"Markussis V, Goni MH, Tolis G. Therapeutic use of gonadotropin-releasing hormone agonists in polycystic ovarian syndrome. Ann N Y Acad Sci. 1993, 687:242-9. 10.1111\/j.1749-6632.1993.tb43872.x","journal-title":"Ann N Y Acad Sci"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198802253180805","article-title":"Administration of nasal nafarelin as compared with oral danazol for endometriosis. A multicenter double-blind comparative clinical trial","volume":"318","author":"Henzl MR","year":"1988","unstructured":"Henzl MR, Corson SL, Moghissi K, Buttram VC, Berqvist C, Jacobson J. Administration of nasal nafarelin as compared with oral danazol for endometriosis. A multicenter double-blind comparative clinical trial. N Engl J Med. 1988, 318:485-9. 10.1056\/NEJM198802253180805","journal-title":"N Engl J Med"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1016\/s0015-0282(16)60543-5","article-title":"Ovarian suppression induced with Buserelin or danazol in the management of endometriosis: a randomized, comparative study","volume":"51","author":"Dmowski WP","year":"1989","unstructured":"Dmowski WP, Radwanska E, Binor Z, Tummon I, Pepping P. Ovarian suppression induced with Buserelin or danazol in the management of endometriosis: a randomized, comparative study. Fertil Steril. 1989, 51:395-400. 10.1016\/s0015-0282(16)60543-5","journal-title":"Fertil Steril"},{"key":"ref42","article-title":"Zoladex (goserelin acetate implant) in the treatment of endometriosis: a randomized comparison with danazol. The Zoladex Endometriosis Study Group","volume":"82","author":"Rock JA","year":"1993","unstructured":"Rock JA, Truglia JA, Caplan RJ. Zoladex (goserelin acetate implant) in the treatment of endometriosis: a randomized comparison with danazol. The Zoladex Endometriosis Study Group. Obstet Gynecol. 1993, 82:198-205.","journal-title":"Obstet Gynecol"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1016\/s0015-0282(99)00636-6","article-title":"Treatment of endometriosis with a decreasing dosage of a gonadotropin-releasing hormone agonist (nafarelin): a pilot study with low-dose agonist therapy (\"draw-back\" therapy)","volume":"73","author":"Tahara M","year":"2000","unstructured":"Tahara M, Matsuoka T, Yokoi T, Tasaka K, Kurachi H, Murata Y. Treatment of endometriosis with a decreasing dosage of a gonadotropin-releasing hormone agonist (nafarelin): a pilot study with low-dose agonist therapy (\"draw-back\" therapy). Fertil Steril. 2000, 73:799-804. 10.1016\/s0015-0282(99)00636-6","journal-title":"Fertil Steril"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1016\/s0015-0282(02)03373-3","article-title":"Effect of prolonged gonadotropin-releasing hormone agonist therapy on the outcome of in vitro fertilization-embryo transfer in patients with endometriosis","volume":"78","author":"Surrey ES","year":"2002","unstructured":"Surrey ES, Silverberg KM, Surrey MW, Schoolcraft WB. Effect of prolonged gonadotropin-releasing hormone agonist therapy on the outcome of in vitro fertilization-embryo transfer in patients with endometriosis. Fertil Steril. 2002, 78:699-704. 10.1016\/s0015-0282(02)03373-3","journal-title":"Fertil Steril"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001750.pub2","article-title":"Gonadotrophin-releasing hormone antagonists for assisted conception","author":"Al-Inany HG","year":"2006","unstructured":"Al-Inany HG, Abou-Setta AM, Aboulghar M. Gonadotrophin-releasing hormone antagonists for assisted conception. Cochrane Database Syst Rev. 2006, CD001750. 10.1002\/14651858.CD001750.pub2","journal-title":"Cochrane Database Syst Rev"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1097\/GCO.0b013e328348a3ce","article-title":"Biochemistry, molecular biology and cell biology of gonadotropin-releasing hormone antagonists","volume":"23","author":"Tan O","year":"2011","unstructured":"Tan O, Bukulmez O. Biochemistry, molecular biology and cell biology of gonadotropin-releasing hormone antagonists. Curr Opin Obstet Gynecol. 2011, 23:238-44. 10.1097\/GCO.0b013e328348a3ce","journal-title":"Curr Opin Obstet Gynecol"},{"key":"ref47","article-title":"Human issues and medical economics of endometriosis. Three- vs. six-month GnRH-agonist therapy","volume":"43","author":"Heinrichs WL","year":"1998","unstructured":"Heinrichs WL, Henzl MR. Human issues and medical economics of endometriosis. Three- vs. six-month GnRH-agonist therapy. J Reprod Med. 1998, 43:299-308.","journal-title":"J Reprod Med"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejogrb.2004.01.033","article-title":"GnRH antagonists","volume":"115 Suppl 1","author":"Coccia ME","year":"2004","unstructured":"Coccia ME, Comparetto C, Bracco GL, Scarselli G. GnRH antagonists. Eur J Obstet Gynecol Reprod Biol. 2004, 115 Suppl 1:S44-56. 10.1016\/j.ejogrb.2004.01.033","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD001750.pub3","article-title":"Gonadotrophin-releasing hormone antagonists for assisted reproductive technology","author":"Al-Inany HG","year":"2011","unstructured":"Al-Inany HG, Youssef MA, Aboulghar M, Broekmans F, Sterrenburg M, Smit J, Abou-Setta AM. Gonadotrophin-releasing hormone antagonists for assisted reproductive technology. Cochrane Database Syst Rev. 2011, CD001750. 10.1002\/14651858.CD001750.pub3","journal-title":"Cochrane Database Syst Rev"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2020.02.114","article-title":"Treatment of endometriosis-associated pain with linzagolix, an oral gonadotropin-releasing hormone-antagonist: a randomized clinical trial","volume":"114","author":"Donnez J","year":"2020","unstructured":"Donnez J, Taylor HS, Taylor RN, et al.. Treatment of endometriosis-associated pain with linzagolix, an oral gonadotropin-releasing hormone-antagonist: a randomized clinical trial. Fertil Steril. 2020, 114:44-55. 10.1016\/j.fertnstert.2020.02.114","journal-title":"Fertil Steril"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2020.07.055","article-title":"Relugolix, an oral gonadotropin-releasing hormone receptor antagonist, reduces endometriosis-associated pain in a dose-response manner: a randomized, double-blind, placebo-controlled study","volume":"115","author":"Osuga Y","year":"2021","unstructured":"Osuga Y, Seki Y, Tanimoto M, Kusumoto T, Kudou K, Terakawa N. Relugolix, an oral gonadotropin-releasing hormone receptor antagonist, reduces endometriosis-associated pain in a dose-response manner: a randomized, double-blind, placebo-controlled study. Fertil Steril. 2021, 115:397-405. 10.1016\/j.fertnstert.2020.07.055","journal-title":"Fertil Steril"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/140112-gonadotropin-releasing-hormone-gnrhgnrh-receptors-and-their-role-in-the-treatment-of-endometriosis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T14:56:05Z","timestamp":1707490565000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/140112-gonadotropin-releasing-hormone-gnrhgnrh-receptors-and-their-role-in-the-treatment-of-endometriosis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4,26]]},"references-count":51,"URL":"https:\/\/doi.org\/10.7759\/cureus.38136","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4,26]]}}}